GENEDX HOLDINGS CORP (WGS) Stock Price, Quote, News and Overview

Company Profile

GeneDx Holdings Corp. is a patient centered health intelligence company. The company is headquartered in Stamford, Connecticut and currently employs 1,000 full-time employees. The company went IPO on 2020-09-04. The firm is focused on delivering personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The firm's segments are GeneDx inclusive of Legacy GeneDx and Legacy Sema4. The GeneDx segment primarily provides pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing and, to a lesser extent, data and information services. GeneDx utilizes an integrated portfolio of laboratory processes, software tools, and informatics capabilities to process deoxyribonucleic acid (DNA)-containing samples, analyze information about patient-specific genetic variation and generate test reports for clinicians and their patients. GeneDx provides a variety of genetic diagnostic tests, screening solutions, and information. The Legacy Sema4 diagnostics segment provides reproductive and women's health and somatic oncology diagnostic testing and screening products.

Company Info

GENEDX HOLDINGS CORP

333 Ludlow Street, North Tower, 8Th Floor

Stamford CONNECTICUT US

Employees: 1000

Company Website: https://sema4.com/

Investor Relations: https://ir.genedx.com/

Phone: 16177808742